| Gene symbol | KLRK1 | Synonyms | CD314, D12S2489E, KLR, NKG2-D, NKG2D | Type of gene | protein-coding |
| Chromosome | 12 | Map location | 12p13.2 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | killer cell lectin like receptor K1 | ||||
| GTO ID | GTC3624 |
| Trial ID | NCT06087341 |
| Disease | Sarcoma |
| Altered gene | NKG2D |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | NKG2D-CAR memory T cell |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | A Phase I Trial of Memory T Cells Expressing an NKG2D Chimeric Antigen Receptor in Children, Adolescents and Young Adults With Advanced Sarcoma |
| Year | 2024 |
| Country | Spain |
| Company sponsor | Antonio Pérez Martínez |
| Other ID(s) | CAR4SAR |
| Cohort 1 | |||||||
|
|||||||